Health & WellnessTech
Extended Longevity, Inc.
Extended Longevity - Phytotherapeutic Antiaging Formulation Protocol.
Kula,
HI
Investment type:
Equity
(Priced Round)
Target raise:
$50,000
- $107,000
Minimum investment:
$100
$100
End date:
Dec 23, 2022
Dec 23, 2022
ended
Share
Highlights
- The Extended Longevity Protocol is an untested way to decelerate the biomarkers of aging.
- The Products are in production and currently selling. Operational facilities on Maui, HI.
- Seasoned Management has taken 3 Companies public for successful exits.
- Epigenome tests show age deceleration of 14 years in a 74 year old man, 12 years in a 58 year woman.
Our Story
Extended Longevity develops and produces anti-aging natural products to decelerate the biomarkers of aging.
Our Ambition
In 5 years Extended Longevity will be a dominant force in the Longevity Biotech industry with over one million satisfied customers enjoying longer, healthier lives.